title: Combining diffusion tensor imaging and magnetic resonance spectroscopy to study reduced frontal white matter integrity in youths with family histories of substance use disorders.
abstract: Individuals with a family history of substance use disorder (FH+) show impaired frontal white matter as indicated by diffusion tensor imaging (DTI). This impairment may be due to impaired or delayed development of myelin in frontal regions, potentially contributing to this population's increased risk for developing substance use disorders. In this study, we examined high angular resolution DTI and proton magnetic resonance spectroscopy data from the anterior corona radiata were collected in 80 FH+ and 34 FH- youths (12.9 ± 1.0 years old). White matter integrity indices included fractional anisotropy (FA), N-acetylaspartate (NAA), and total choline (tCho). Lower FA suggests decreased myelination. Decreased NAA coupled with higher tCho suggests impaired build-up and maintenance of cerebral myelin and consequently greater breakdown of cellular membranes. We found FH+ youths had lower FA (P < 0.0001) and NAA (P = 0.017) and higher tCho (P = 0.04). FH density (number of parents and grandparents with substance use disorders) was negatively correlated with FA (P < 0.0001) and NAA (P = 0.011) and positively correlated with tCho (P = 0.001). FA was independently predicted by both FH density (P = 0.006) and NAA (P = 0.002), and NAA and tCho were both independent predictors of FH density (P < 0.001). Our finding of lower frontal FA in FH+ youths corresponding to lower NAA and increased tCho is consistent with delayed or impaired development of frontal white matter in FH+ youths. Longitudinal studies are needed to determine how these differences relate to substance use outcomes.
authors.affiliation: Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas; Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
authors.forename: Ashley
authors.initials: A
authors.lastname: Acheson
authors.forename: S Andrea
authors.initials: SA
authors.lastname: Wijtenburg
authors.forename: Laura M
authors.initials: LM
authors.lastname: Rowland
authors.forename: Bethany C
authors.initials: BC
authors.lastname: Bray
authors.forename: Frank
authors.initials: F
authors.lastname: Gaston
authors.forename: Charles W
authors.initials: CW
authors.lastname: Mathias
authors.forename: Peter T
authors.initials: PT
authors.lastname: Fox
authors.forename: William R
authors.initials: WR
authors.lastname: Lovallo
authors.forename: Susan N
authors.initials: SN
authors.lastname: Wright
authors.forename: L Elliot
authors.initials: LE
authors.lastname: Hong
authors.forename: Stephen
authors.initials: S
authors.lastname: McGuire
authors.forename: Peter
authors.initials: P
authors.lastname: Kochunov
authors.forename: Donald M
authors.initials: DM
authors.lastname: Dougherty
mesh_terms: D000293:Adolescent; D016880:Anisotropy; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D001921:Brain / Q000378:metabolism* / Q000473:pathology*; D002648:Child; D002794:Choline / Q000378:metabolism; D056324:Diffusion Tensor Imaging; D005190:Family; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D064847:Multimodal Imaging; D066244:Proton Magnetic Resonance Spectroscopy; D012044:Regression Analysis; D012306:Risk; D019966:Substance-Related Disorders / Q000378:metabolism* / Q000473:pathology*; D066127:White Matter / Q000378:metabolism* / Q000473:pathology*
chemical_list: D001224:Aspartic Acid; C000179:N-acetylaspartate; D002794:Choline
keywords: diffusion tensor imaging; family history; frontal white matter integrity; proton magnetic resonance spectroscopy; risk; substance use